AN vs GAP

AutoNation's deterministic health scores raise significant concerns, with a weak Piotroski F-Score of 3/9 indicating poor financial health, and no available Altman Z-Score limits distress risk assessment. Despite this, the company shows strong recent earnings growth (22.6% YoY) and beats on earnings surprises, supported by a bullish analyst recommendation and a forward P/E of 10.12 that appears cheap relative to sector peers. However, high leverage (Debt/Equity of 3.90), weak liquidity (Current Ratio 0.79), and declining Q/Q EPS (-8.2%) offset these positives. The stock trades below the growth-based intrinsic value of $490 but above the conservative Graham Number of $159.54, suggesting mixed valuation signals.

GAP exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9, indicating solid operational improvement despite a lack of Altman Z-Score data. However, the stock is currently trading at a premium to both its Graham Number ($22.13) and Intrinsic Value ($14.91), suggesting limited valuation upside. While the balance sheet is stable and the P/E ratio is low relative to the sector, significant headwinds include negative earnings growth (-16% YoY) and a starkly bearish insider sentiment. The disconnect between analyst 'Buy' ratings and the 0/100 technical trend suggests a high-risk environment for new entries.